ArticleBreast cancer research and treatment2022

A comparative analysis of recurrence risk predictions in ER+/HER2- early breast cancer using NHS Nottingham Prognostic Index, PREDICT, and CanAssist Breast.

Aparna Gunda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.